2 results
Approved WMOCompleted
Primary: Progression Free Survival (PFS) in patients treated with AUY922 versus pemetrexed or docetaxel.Secondary: Overall response rate, disease control rate, overall survival, safety and tolerability, PK.
Approved WMORecruiting
Primary objective: Is there a difference in the change in perfused vessel density between obese and lean subjects after cardiac surgery with cardiopulmonary bypass?Secondary Objectives * Is there a difference in baseline perfused vessel density…